{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T05:28:44Z","timestamp":1790054924250,"version":"4.0.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971291"],"award-info":[{"award-number":["81971291"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Wenzhou Municipal Science and Technology Bureau of China","award":["ZY2022002"],"award-info":[{"award-number":["ZY2022002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-024-05571-3","type":"journal-article","created":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T10:03:00Z","timestamp":1723629780000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Gene therapy in A\u03b2-induced cell and mouse models of Alzheimer\u2019s disease through compensating defective mitochondrial complex I function"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8662-5145","authenticated-orcid":false,"given":"Hongzhi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyou","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luxi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,14]]},"reference":[{"issue":"2","key":"5571_CR1","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","volume":"179","author":"JM Long","year":"2019","unstructured":"Long JM, Holtzman DM. Alzheimer Disease: an update on pathobiology and treatment strategies. Cell. 2019;179(2):312\u201339.","journal-title":"Cell"},{"key":"5571_CR2","doi-asserted-by":"publisher","first-page":"603854","DOI":"10.3389\/fnagi.2020.603854","volume":"12","author":"L Cui","year":"2020","unstructured":"Cui L, Hou NN, Wu HM, Zuo X, Lian YZ, Zhang CN, et al. Prevalence of Alzheimer\u2019s Disease and Parkinson\u2019s Disease in China: an updated Systematical Analysis. Front Aging Neurosci. 2020;12:603854.","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"5571_CR3","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","volume":"7","author":"GBDDF Collaborators","year":"2022","unstructured":"Collaborators GBDDF. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the global burden of Disease Study 2019. Lancet Public Health. 2022;7(2):e105\u201325.","journal-title":"Lancet Public Health"},{"issue":"5","key":"5571_CR4","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s11011-021-00683-x","volume":"36","author":"U Saleem","year":"2021","unstructured":"Saleem U, Akhtar R, Anwar F, Shah MA, Chaudary Z, Ayaz M, et al. Neuroprotective potential of Malva neglecta is mediated via down-regulation of cholinesterase and modulation of oxidative stress markers. Metab Brain Dis. 2021;36(5):889\u2013900.","journal-title":"Metab Brain Dis"},{"issue":"7","key":"5571_CR5","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","volume":"14","author":"EE Congdon","year":"2018","unstructured":"Congdon EE, Sigurdsson EM. Tau-targeting therapies for Alzheimer disease. Nat Rev Neurol. 2018;14(7):399\u2013415.","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"5571_CR6","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1007\/s00415-021-10790-5","volume":"269","author":"J Pleen","year":"2022","unstructured":"Pleen J, Townley R. Alzheimer\u2019s disease clinical trial update 2019\u20132021. J Neurol. 2022;269(2):1038\u201351.","journal-title":"J Neurol"},{"issue":"1","key":"5571_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, et al. Lecanemab in Early Alzheimer\u2019s Disease. N Engl J Med. 2023;388(1):9\u201321.","journal-title":"N Engl J Med"},{"issue":"3","key":"5571_CR8","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.3233\/JAD-170585","volume":"62","author":"RH Swerdlow","year":"2018","unstructured":"Swerdlow RH. Mitochondria and mitochondrial cascades in Alzheimer\u2019s Disease. J Alzheimers Dis. 2018;62(3):1403\u201316.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"5571_CR9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.5483\/BMBRep.2020.53.1.279","volume":"53","author":"JW Lim","year":"2020","unstructured":"Lim JW, Lee J, Pae AN. Mitochondrial dysfunction and Alzheimer\u2019s disease: prospects for therapeutic intervention. BMB Rep. 2020;53(1):47\u201355.","journal-title":"BMB Rep"},{"issue":"40","key":"5571_CR10","doi-asserted-by":"publisher","first-page":"5578","DOI":"10.2174\/0929867324666170616110111","volume":"25","author":"C Desler","year":"2018","unstructured":"Desler C, Lillenes MS, Tonjum T, Rasmussen LJ. The role of mitochondrial dysfunction in the progression of Alzheimer\u2019s Disease. Curr Med Chem. 2018;25(40):5578\u201387.","journal-title":"Curr Med Chem"},{"issue":"3","key":"5571_CR11","doi-asserted-by":"publisher","first-page":"751","DOI":"10.3233\/JAD-221286","volume":"92","author":"RH Swerdlow","year":"2023","unstructured":"Swerdlow RH. The Alzheimer\u2019s disease mitochondrial Cascade hypothesis: a current overview. J Alzheimers Dis. 2023;92(3):751\u201368.","journal-title":"J Alzheimers Dis"},{"issue":"2\u20133","key":"5571_CR12","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s12035-010-8109-5","volume":"41","author":"A Eckert","year":"2010","unstructured":"Eckert A, Schulz KL, Rhein V, Gotz J. Convergence of amyloid-beta and tau pathologies on mitochondria in vivo. Mol Neurobiol. 2010;41(2\u20133):107\u201314.","journal-title":"Mol Neurobiol"},{"issue":"1","key":"5571_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13041-019-0430-y","volume":"12","author":"SS Adav","year":"2019","unstructured":"Adav SS, Park JE, Sze SK. Quantitative profiling brain proteomes revealed mitochondrial dysfunction in Alzheimer\u2019s disease. Mol Brain. 2019;12(1):8.","journal-title":"Mol Brain"},{"issue":"5","key":"5571_CR14","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1111\/ene.15246","volume":"29","author":"T Terada","year":"2022","unstructured":"Terada T, Therriault J, Kang MS, Savard M, Pascoal TA, Lussier F, et al. Mitochondrial complex I abnormalities underlie neurodegeneration and cognitive decline in Alzheimer\u2019s disease. Eur J Neurol. 2022;29(5):1324\u201334.","journal-title":"Eur J Neurol"},{"issue":"1","key":"5571_CR15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s10020-022-00456-x","volume":"28","author":"H Li","year":"2022","unstructured":"Li H, Sun B, Huang Y, Zhang J, Xu X, Shen Y, et al. Gene therapy of yeast NDI1 on mitochondrial complex I dysfunction in rotenone-induced Parkinson\u2019s disease models in vitro and vivo. Mol Med. 2022;28(1):29.","journal-title":"Mol Med"},{"key":"5571_CR16","doi-asserted-by":"crossref","unstructured":"Lueptow LM. Novel object Recognition Test for the investigation of learning and memory in mice. J Vis Exp. 2017(126).","DOI":"10.3791\/55718-v"},{"issue":"2","key":"5571_CR17","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/nprot.2006.116","volume":"1","author":"CV Vorhees","year":"2006","unstructured":"Vorhees CV, Williams MT. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc. 2006;1(2):848\u201358.","journal-title":"Nat Protoc"},{"issue":"4","key":"5571_CR18","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.drudis.2022.01.016","volume":"27","author":"SA Tatulian","year":"2022","unstructured":"Tatulian SA. Challenges and hopes for Alzheimer\u2019s disease. Drug Discov Today. 2022;27(4):1027\u201343.","journal-title":"Drug Discov Today"},{"issue":"7","key":"5571_CR19","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1093\/brain\/awy132","volume":"141","author":"H Hampel","year":"2018","unstructured":"Hampel H, Mesulam MM, Cuello AC, Farlow MR, Giacobini E, Grossberg GT, et al. The cholinergic system in the pathophysiology and treatment of Alzheimer\u2019s disease. Brain. 2018;141(7):1917\u201333.","journal-title":"Brain"},{"issue":"1","key":"5571_CR20","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13024-020-00376-6","volume":"15","author":"W Wang","year":"2020","unstructured":"Wang W, Zhao F, Ma X, Perry G, Zhu X. Mitochondria dysfunction in the pathogenesis of Alzheimer\u2019s disease: recent advances. Mol Neurodegener. 2020;15(1):30.","journal-title":"Mol Neurodegener"},{"issue":"18","key":"5571_CR21","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1111\/bph.14585","volume":"176","author":"JM Perez Ortiz","year":"2018","unstructured":"Perez Ortiz JM, Swerdlow RH. Mitochondrial dysfunction in Alzheimer\u2019s disease: role in pathogenesis and novel therapeutic opportunities. Br J Pharmacol. 2018;176(18):3489\u2013507.","journal-title":"Br J Pharmacol"},{"issue":"10284","key":"5571_CR22","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chetelat G, Teunissen CE, et al. Alzheimer\u2019s disease. Lancet. 2021;397(10284):1577\u201390.","journal-title":"Lancet"},{"issue":"1","key":"5571_CR23","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/alz.12683","volume":"19","author":"T Ashleigh","year":"2023","unstructured":"Ashleigh T, Swerdlow RH, Beal MF. The role of mitochondrial dysfunction in Alzheimer\u2019s disease pathogenesis. Alzheimers Dement. 2023;19(1):333\u201342.","journal-title":"Alzheimers Dement"},{"key":"5571_CR24","doi-asserted-by":"publisher","first-page":"111828","DOI":"10.1016\/j.exger.2022.111828","volume":"164","author":"AB Reiss","year":"2022","unstructured":"Reiss AB, Ahmed S, Dayaramani C, Glass AD, Gomolin IH, Pinkhasov A, et al. The role of mitochondrial dysfunction in Alzheimer\u2019s disease: a potential pathway to treatment. Exp Gerontol. 2022;164:111828.","journal-title":"Exp Gerontol"},{"key":"5571_CR25","doi-asserted-by":"publisher","first-page":"102734","DOI":"10.1016\/j.redox.2023.102734","volume":"63","author":"Y Han","year":"2023","unstructured":"Han Y, Liu D, Cheng Y, Ji Q, Liu M, Zhang B, et al. Maintenance of mitochondrial homeostasis for Alzheimer\u2019s disease: strategies and challenges. Redox Biol. 2023;63:102734.","journal-title":"Redox Biol"},{"key":"5571_CR26","doi-asserted-by":"publisher","first-page":"1199625","DOI":"10.3389\/fnins.2023.1199625","volume":"17","author":"W Guo","year":"2023","unstructured":"Guo W, Hassan LA, Chu YH, Yang XP, Wang SX, Zhu HX, et al. Mapping trends and hotspots of mitochondrial dysfunction in Alzheimer\u2019s disease from 2013 to 2022: a bibliometric analysis of global research. Front Neurosci. 2023;17:1199625.","journal-title":"Front Neurosci"},{"issue":"7","key":"5571_CR27","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.bbabio.2016.02.012","volume":"1857","author":"RJ Rodenburg","year":"2016","unstructured":"Rodenburg RJ. Mitochondrial complex I-linked disease. Biochim Biophys Acta. 2016;1857(7):938\u201345.","journal-title":"Biochim Biophys Acta"},{"key":"5571_CR28","doi-asserted-by":"crossref","unstructured":"Fisar Z. Linking the Amyloid, Tau, and Mitochondrial Hypotheses of Alzheimer\u2019s Disease and Identifying Promising Drug Targets. Biomolecules. 2022;12(11).","DOI":"10.3390\/biom12111676"},{"issue":"1","key":"5571_CR29","doi-asserted-by":"publisher","first-page":"e12179","DOI":"10.1002\/trc2.12179","volume":"7","author":"J Cummings","year":"2021","unstructured":"Cummings J, Lee G, Zhong K, Fonseca J, Taghva K. Alzheimer\u2019s disease drug development pipeline: 2021. Alzheimers Dement (N Y). 2021;7(1):e12179.","journal-title":"Alzheimers Dement (N Y)"},{"issue":"1","key":"5571_CR30","doi-asserted-by":"publisher","first-page":"e12295","DOI":"10.1002\/trc2.12295","volume":"8","author":"J Cummings","year":"2022","unstructured":"Cummings J, Lee G, Nahed P, Kambar M, Zhong K, Fonseca J, et al. Alzheimer\u2019s disease drug development pipeline: 2022. Alzheimers Dement (N Y). 2022;8(1):e12295.","journal-title":"Alzheimers Dement (N Y)"},{"issue":"1","key":"5571_CR31","doi-asserted-by":"publisher","first-page":"e12050","DOI":"10.1002\/trc2.12050","volume":"6","author":"J Cummings","year":"2020","unstructured":"Cummings J, Lee G, Ritter A, Sabbagh M, Zhong K. Alzheimer\u2019s disease drug development pipeline: 2020. Alzheimers Dement (N Y). 2020;6(1):e12050.","journal-title":"Alzheimers Dement (N Y)"},{"key":"5571_CR32","doi-asserted-by":"crossref","unstructured":"Congdon EE, Ji C, Tetlow AM, Jiang Y, Sigurdsson EM. Tau-targeting therapies for Alzheimer disease: current status and future directions. Nat Rev Neurol. 2023.","DOI":"10.1038\/s41582-023-00883-2"},{"issue":"1","key":"5571_CR33","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/joim.12759","volume":"284","author":"R Loera-Valencia","year":"2018","unstructured":"Loera-Valencia R, Piras A, Ismail MAM, Manchanda S, Eyjolfsdottir H, Saido TC, et al. Targeting Alzheimer\u2019s disease with gene and cell therapies. J Intern Med. 2018;284(1):2\u201336.","journal-title":"J Intern Med"},{"issue":"17","key":"5571_CR34","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1093\/hmg\/ddaa179","volume":"29","author":"A Griciuc","year":"2020","unstructured":"Griciuc A, Federico AN, Natasan J, Forte AM, McGinty D, Nguyen H, et al. Gene therapy for Alzheimer\u2019s disease targeting CD33 reduces amyloid beta accumulation and neuroinflammation. Hum Mol Genet. 2020;29(17):2920\u201335.","journal-title":"Hum Mol Genet"},{"issue":"4","key":"5571_CR35","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/mp.2016.112","volume":"22","author":"R Derungs","year":"2016","unstructured":"Derungs R, Camici GG, Spescha RD, Welt T, Tackenberg C, Spani C, et al. Genetic ablation of the p66(shc) adaptor protein reverses cognitive deficits and improves mitochondrial function in an APP transgenic mouse model of Alzheimer\u2019s disease. Mol Psychiatry. 2016;22(4):605\u201314.","journal-title":"Mol Psychiatry"},{"issue":"4","key":"5571_CR36","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1001\/jamaophthalmol.2013.7630","volume":"132","author":"RD Koilkonda","year":"2014","unstructured":"Koilkonda RD, Yu H, Chou TH, Feuer WJ, Ruggeri M, Porciatti V, et al. Safety and effects of the vector for the Leber hereditary optic neuropathy gene therapy clinical trial. JAMA Ophthalmol. 2014;132(4):409\u201320.","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"5571_CR37","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1177\/1074248413515750","volume":"19","author":"RM Mentzer Jr","year":"2014","unstructured":"Mentzer RM Jr., Wider J, Perry CN, Gottlieb RA. Reduction of infarct size by the therapeutic protein TAT-Ndi1 in vivo. J Cardiovasc Pharmacol Ther. 2014;19(3):315\u201320.","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"1","key":"5571_CR38","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1038\/s41467-023-36894-2","volume":"14","author":"B Jimenez-Gomez","year":"2023","unstructured":"Jimenez-Gomez B, Ortega-Saenz P, Gao L, Gonzalez-Rodriguez P, Garcia-Flores P, Chandel N, et al. Transgenic NADH dehydrogenase restores oxygen regulation of breathing in mitochondrial complex I-deficient mice. Nat Commun. 2023;14(1):1172.","journal-title":"Nat Commun"},{"issue":"4","key":"5571_CR39","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1007\/s12035-019-01857-6","volume":"57","author":"V Talla","year":"2020","unstructured":"Talla V, Koilkonda R, Guy J. Gene Therapy with single-subunit yeast NADH-Ubiquinone oxidoreductase (NDI1) improves the visual function in experimental autoimmune encephalomyelitis (EAE) mice model of multiple sclerosis (MS). Mol Neurobiol. 2020;57(4):1952\u201365.","journal-title":"Mol Neurobiol"},{"issue":"10","key":"5571_CR40","doi-asserted-by":"publisher","first-page":"e25910","DOI":"10.1371\/journal.pone.0025910","volume":"6","author":"M Marella","year":"2011","unstructured":"Marella M, Seo BB, Flotte TR, Matsuno-Yagi A, Yagi T. No immune responses by the expression of the yeast Ndi1 protein in rats. PLoS ONE. 2011;6(10):e25910.","journal-title":"PLoS ONE"},{"issue":"6","key":"5571_CR41","doi-asserted-by":"publisher","first-page":"931","DOI":"10.4103\/1673-5374.250570","volume":"14","author":"Y Qu","year":"2019","unstructured":"Qu Y, Liu Y, Noor AF, Tran J, Li R. Characteristics and advantages of adeno-associated virus vector-mediated gene therapy for neurodegenerative diseases. Neural Regeneration Res. 2019;14(6):931\u20138.","journal-title":"Neural Regeneration Res"},{"issue":"12","key":"5571_CR42","doi-asserted-by":"publisher","first-page":"3632","DOI":"10.1016\/j.ymthe.2022.08.003","volume":"30","author":"MT Rocco","year":"2022","unstructured":"Rocco MT, Akhter AS, Ehrlich DJ, Scott GC, Lungu C, Munjal V, et al. Long-term safety of MRI-guided administration of AAV2-GDNF and gadoteridol in the putamen of individuals with Parkinson\u2019s disease. Mol Ther. 2022;30(12):3632\u20138.","journal-title":"Mol Ther"},{"issue":"7","key":"5571_CR43","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1001\/jamaneurol.2018.0233","volume":"75","author":"MS Rafii","year":"2018","unstructured":"Rafii MS, Tuszynski MH, Thomas RG, Barba D, Brewer JB, Rissman RA, et al. Adeno-Associated viral vector (serotype 2)-Nerve growth factor for patients with Alzheimer Disease: a Randomized Clinical Trial. JAMA Neurol. 2018;75(7):834\u201341.","journal-title":"JAMA Neurol"},{"issue":"9","key":"5571_CR44","doi-asserted-by":"publisher","first-page":"e76310","DOI":"10.1371\/journal.pone.0076310","volume":"8","author":"DF Aschauer","year":"2013","unstructured":"Aschauer DF, Kreuz S, Rumpel S. Analysis of transduction efficiency, tropism and axonal transport of AAV serotypes 1, 2, 5, 6, 8 and 9 in the mouse brain. PLoS ONE. 2013;8(9):e76310.","journal-title":"PLoS ONE"},{"key":"5571_CR45","doi-asserted-by":"crossref","unstructured":"Lee Y, Ju YJ, Gee MS, Jeon SH, Kim N, Koo T et al. Survivin enhances hippocampal neurogenesis and cognitive function in Alzheimer\u2019s disease mouse model. CNS Neurosci Ther. 2023.","DOI":"10.1111\/cns.14509"},{"key":"5571_CR46","doi-asserted-by":"publisher","first-page":"109614","DOI":"10.1016\/j.intimp.2022.109614","volume":"117","author":"G Zhou","year":"2023","unstructured":"Zhou G, Ye Q, Xu Y, He B, Wu L, Zhu G, et al. Mitochondrial calcium uptake 3 mitigates cerebral amyloid angiopathy-related neuronal death and glial inflammation by reducing mitochondrial dysfunction. Int Immunopharmacol. 2023;117:109614.","journal-title":"Int Immunopharmacol"},{"key":"5571_CR47","doi-asserted-by":"crossref","unstructured":"Gomez Limia C, Baird M, Schwartz M, Saxena S, Meyer K, Wein N. Emerging perspectives on Gene Therapy Delivery for neurodegenerative and neuromuscular disorders. J Pers Med. 2022;12(12).","DOI":"10.3390\/jpm12121979"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05571-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-024-05571-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05571-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T10:07:42Z","timestamp":1723630062000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-024-05571-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,14]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5571"],"URL":"https:\/\/doi.org\/10.1186\/s12967-024-05571-3","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,14]]},"assertion":[{"value":"9 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted according to the guidelines of Declaration of Helsinki, and approved by the Institutional Animal Care & Use Committee of Wenzhou Medical University in Wenzhou, China (wydw2022-0236). Not applicable for consent to participate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"760"}}